# OnCo record pilatus-biosciences (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/pilatus-biosciences/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "pilatus-biosciences" ;
  schema:name "Pilatus Biosciences"@en ;
  schema:alternateName "Pilatus Biosciences Inc"@en, "Pilatus Biosciences SA"@en ;
  schema:description "Pilatus Biosciences develops PLT012, an antibody that blocks how certain cells in a tumour take up fat, aiming to weaken cells that suppress the immune system and strengthen those that attack cancer. It is in an early trial in advanced solid tumours, including liver cancer."@en ;
  schema:url <https://onco.cc/companies/pilatus-biosciences/>, <https://www.pilatusbio.com/> ;
  schema:dateModified "2026-10-29"^^xsd:date ;
  schema:citation <https://www.pilatusbio.com/>, <https://www.pilatusbio.com/latest-news/pilatus-biosciences-announces-first-patient-dosed-in-hong-kong-clinical-trial-of-plt012-for-liver-cancer-expansion>, <https://clinicaltrials.gov/study/NCT07337525> ;
  schema:addressCountry "CH" ;
  onco:cancers <https://onco.cc/cancers/hcc/>, <https://onco.cc/cancers/intrahepatic-cholangiocarcinoma/> ;
  onco:sections <https://onco.cc/fronts/immunotherapy/> ;
  onco:technologies <https://onco.cc/technologies/monoclonal-antibody/> .